The Anti-Cancer Potency and Mechanism of a Novel Tumor-Activated Fused Toxin, DLM
AbstractMelittin, which acts as a membrane-disrupting lytic peptide, is not only cytotoxic to tumors, but also vital to normal cells. Melittin had low toxicity when coupled with target peptides. Despite significant research development with the fused toxin, a new fused toxin is needed which has a cleavable linker such that the fused toxin can release melittin after protease cleavage on the tumor cell surface. We describe a novel fused toxin, composed of disintegrin, uPA (urokinase-type plasminogen activator)-cleavable linker, and melittin. Disintegrin is a single strand peptide (73 aa) isolated from Gloydius Ussuriensis venom. The RGD (Arg-Gly-Asp) site of disintegrin dominates its interaction with integrins on the surface of the tumor cells. uPA is over-expressed and plays an important role in tumor cell invasiveness and metastatic progression. The DLM (disintegrin-linker-melittin) linker is uPA-cleavable, enabling DLM to release melittin. We compared binding activity of our synthesized disintegrin with native disintegrin and report that DLM had less binding activity than the native form. uPA-cleavage was evaluated in vitro and the uPA-cleavable linker released melittin. Treating tumors expressing uPA with DLM enhanced tumor cell killing as well as reduced toxicity to erythrocytes and other non-cancerous normal cells. The mechanism behind DLM tumor cell killing was tested using a DNA ladder assay, fluorescent microscopy, flow cytometry, and transmission electron microscopy. Data revealed tumor cell necrosis as the mechanism of cell death, and the fused DLM toxin with an uPA-cleavable linker enhanced tumor selectivity and killing ability. View Full-Text
- Supplementary File 1:
Supplementary Materials (PDF, 357 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Sun, D.; Sun, M.; Zhu, W.; Wang, Z.; Li, Y.; Ma, J. The Anti-Cancer Potency and Mechanism of a Novel Tumor-Activated Fused Toxin, DLM. Toxins 2015, 7, 423-438.
Sun D, Sun M, Zhu W, Wang Z, Li Y, Ma J. The Anti-Cancer Potency and Mechanism of a Novel Tumor-Activated Fused Toxin, DLM. Toxins. 2015; 7(2):423-438.Chicago/Turabian Style
Sun, Dejun; Sun, Miaonan; Zhu, Wenhe; Wang, Zhiding; Li, Yuefei; Ma, Jie. 2015. "The Anti-Cancer Potency and Mechanism of a Novel Tumor-Activated Fused Toxin, DLM." Toxins 7, no. 2: 423-438.